Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

Dana-Farber Cancer Institute Presidential Symposium

Presidential Symposium panelists

Spring 2023
By Colleen Sullivan
Photography by Justin Knight

In October, Dana-Farber supporters and leaders gathered for the annual Dana-Farber Cancer Institute Presidential Symposium. Attendees received firsthand updates on the State of the Institute, advances and opportunities in prevention and early detection, the impact of philanthropy on advancing research, and Dana-Farber’s world-renowned hematology/oncology fellowship program. Pictured are fellowship program graduates and panelists (from left): Ann LaCasce, MD, MMSc, program director and the Fellowship Program in Hematology/Oncology Chair at Dana-Farber; Levi Garraway, MD, PhD, EVP, head of global product development and chief medical officer, Roche and Genentech; and Nadine McCleary, MD, MPH, medical director, Patient Reported Data Program at Dana-Farber.

Copy link
Powered by Social Snap